46岁药企董事长，因涉嫌刑事犯罪被批捕

Core Viewpoint - The chairman and president of North Medical Pharmaceutical, Xu Xiren, has been arrested for criminal charges, leading to a temporary change in leadership, but the company's control and operations remain stable [1][3]. Group 1: Company Leadership and Management - Xu Xiren has been arrested by the Chongqing Jiangbei District People's Procuratorate for suspected criminal activities [1]. - Following Xu's arrest, Director Chen Yuezhong is acting as chairman, while Executive Vice President Yu Mengchuan is fulfilling the roles of president and legal representative [3]. - The company’s control has not changed, and the board of directors is functioning normally [3]. Group 2: Company Performance - For Q3, North Medical Pharmaceutical reported a revenue of 274 million, a year-on-year decrease of 47.95%, and a net profit attributable to shareholders of 35.6867 million, down 18.04% [3]. - For the first three quarters, the company achieved a revenue of 1.231 billion, a decline of 19.76%, while the net profit attributable to shareholders was 136 million, an increase of 4.31% [3]. Group 3: Company Background - North Medical Pharmaceutical was established in 1965 and listed on the Shenzhen Stock Exchange in 1997. It became a member of the Ping An Group in 2022 [4]. - The company has undergone two rounds of actual controller changes, with Xu Xiren becoming the actual controller in December 2024, and it currently has no direct relationship with Peking University [4]. Group 4: Market Performance - The stock price of North Medical Pharmaceutical has been rising recently, with a market capitalization of 3.98 billion as of November 12 [5].